Advanced Treatment Approaches

Treating high blood pressure can take a multi-pronged approach including diet changes, medication, and exercise. Hypertension, or high blood pressure, is dangerous because it can lead to strokes, heart attacks, heart failure, or kidney disease. The goal of hypertension treatment is to lower high blood pressure and protect important organs, like the brain, heart, and kidneys from damage. Treatment for hypertension has been associated with reductions in stroke (reduced an average of 35%-40%), heart attack (20%-25%), and heart failure (more than 50%), according to research.                            

Because hypertension rarely causes specific symptoms, it is not identified until an individual’s blood pressure is measured by a physician or it causes a catastrophic complication such as stroke or heart attack.Accurate diagnosis by blood pressure measurement is essential. Many advanced treatment approaches and medications have been established for the treatment and management of hypertension that may describe this session.

Related Conferences:

  1. 4th Personalized Medicine Conference, September 19-21, 2016 Phoenix, USA
  2. 2nd Molecular Medicine & Diagnosis Conference, September 26-28, 2016 Miami, USA
  3. 5th Pathology Conference, May 09-11, 2016 Chicago, USA
  4. 2nd Cytopathology Conference, August 11-12, 2016 Birmingham , UK
  5. 2nd Clinical Case Reports Conference, April 18-20, 2016 Dubai, UAE
  6. Pulmonary Hypertension: Next Generation 2015, London, UK
  7. Hypertension Summit 2015, London, UK
  8. 2015 International conference for innovations in cardiovascular systems, Tel Aviv, Israel
  9. CARDIOTECHNIX 2015 — 3rd International Congress on Cardiovascular Technologies, Lisbon, Portugal
  10. XXII. World Congress of Echocardiography and Cardiology, Istanbul, Turkey


The renin–angiotensin system (RAS) or the renin–angiotensin–aldosterone system (RAAS) is a hormone system that regulates blood pressure and fluid balance. Calcium channel blockers (CCB), calcium channel antagonists or calcium antagonists are several medications that disrupt the movement of calcium (Ca2+
) through calcium channels. Calcium channel blockers are used as antihypertensive drugs, i.e., as medications to decrease blood pressure in patients with hypertension. When blood vessels dilate, the flow of blood is increased due to a decrease in vascular resistance. Therefore, dilation of arterial blood vessels (mainly the arterioles) decreases blood pressure. Drugs that cause vasodilation are termed vasodilators. The wide variety of antihypertensive agents now available allows considerable flexibility in the pharmacologic management of hypertension. The newly available alpha- and beta-adrenergic blocking agents have added considerably to this flexibility.

  • Renin-angiotensin system
  • Mechanisms of drug action
  • Calcium-channel blockers
  • Combined alpha and beta-blockers
  • Central agonists
  • Blood vessel dilators (vasodilators)

Related Conference of Advanced Treatment Approaches

September 12-13, 2016

11th Annual Cardiology Summit

Philadelphia, Pennsylvania, USA
October 20-21, 2016

Global Summit on Heart Diseases

Chicago, Illinois, USA
November 14-16, 2016

14th International Conference on Clinical & Experimental Cardiology

Orlando, Florida, USA
December 08-09, 2016

15th World Cardiac Surgery & Angiology Conference

Philadelphia, Pennsylvania, USA
December 05-06, 2016

13th European Cardiology Conference

Madrid, Spain
December 08-10, 2016

16th World Cardiology Congress

Dubai, UAE
March 15-17, 2017

Annual Conference on Cardiology

London, UK
March 15-17, 2017

Annual Conference on Cardiology

London, UK
May 22-24, 2017

World Heart Congress

Osaka, Japan
June 19-21, 2017

17th Global Cardiologists Annual Meeting

Paris, France
Sep 11-13, 2017

2nd International Conference on Hypertension & Health Care

Amsterdam, Netherlands
October 17-18, 2017

International Conference on Angiology

Budapest, Hungary

Advanced Treatment Approaches Conference Speakers

Recommended Sessions

Related Journals

Are you interested in